Literature DB >> 308712

Dispersity of human factor VIII--Von Willebrand factor.

J A van Mourik, P A Bolhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 308712     DOI： 10.1016/0049-3848(78)90105-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

1.  Structural analysis of factor VIII antigen in von Willebrand disease.

Authors:  R L Nachman; E A Jaffe; C Miller; W T Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

2.  Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture.

Authors:  R L Nachman
Journal:  West J Med       Date:  1982-04

3.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Authors:  A Leyte; J Voorberg; H B Van Schijndel; B Duim; H Pannekoek; J A Van Mourik
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.

Authors:  C L Verweij; P J Diergaarde; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

5.  Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.

Authors:  J Voorberg; R Fontijn; J A van Mourik; H Pannekoek
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

6.  Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids.

Authors:  J Voorberg; R Fontijn; J Calafat; H Janssen; J A van Mourik; H Pannekoek
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

7.  Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.

Authors:  C L Verweij; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.